The macrophage foam cell as a target for therapeutic intervention. - Wikidata - awgldk - TriplyDB

The macrophage foam cell as a target for therapeutic intervention.

The macrophage foam cell as a target for therapeutic intervention.

http://www.wikidata.org/entity/Q34986351

about

PPAR(alpha) and PPAR(gamma) activators suppress the monocyte-macrophage apoB-48 receptor Extracellular Release and Signaling by Heat Shock Protein 27: Role in Modifying Vascular Inflammation Macrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on Atherosclerosis Macrophages in vascular inflammation--From atherosclerosis to vasculitis Apoptotic cell clearance: basic biology and therapeutic potential.Redox status in mammalian cells and stem cells during culture in vitro: critical roles of Nrf2 and cystine transporter activity in the maintenance of redox balance Epigenome-guided analysis of the transcriptome of plaque macrophages during atherosclerosis regression reveals activation of the Wnt signaling pathway Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells 3-nitrotyrosine modified proteins in atherosclerosis Arsenic exacerbates atherosclerotic lesion formation and inflammation in ApoE-/- mice Protective and pathogenic functions of macrophage subsets The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system.Nuclear receptors as drug targets for metabolic disease.CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages.Emerging diagnostic and therapeutic molecular imaging applications in vascular disease Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics Mechanisms of nanoparticle-mediated photomechanical cell damage Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation.Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions Translation inhibitors induce formation of cholesterol ester-rich lipid droplets.Fibrin D-dimer fragments enhance inflammatory responses in macrophages: role in advancing atherosclerosis.Intracellular degradation of microspheres based on cross-linked dextran hydrogels or amphiphilic block copolymers: a comparative raman microscopy study.Gold nanorod-mediated photothermolysis induces apoptosis of macrophages via damage of mitochondria.Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice.ABCG1 rs57137919G>a polymorphism is functionally associated with varying gene expression and apoptosis of macrophages.The expression of a disintegrin and metalloproteinase with thrombospondin motifs 4 in human macrophages is inhibited by the anti-atherogenic cytokine transforming growth factor-β and requires Smads, p38 mitogen-activated protein kinase and c-Jun You are right too!Therapeutic approaches to drug targets in atherosclerosis.Early decrease in carotid plaque lipid content as assessed by magnetic resonance imaging during treatment of rosuvastatin.A macrophage sterol-responsive network linked to atherogenesis Targeted deletions of cyclooxygenase-2 and atherogenesis in mice.Direct-contact co-culture between smooth muscle and endothelial cells inhibits TNF-alpha-mediated endothelial cell activation.Macrophage polarization to a unique phenotype driven by B cells.SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis Impact of hydrophobic chain composition on amphiphilic macromolecule antiatherogenic bioactivity Adenosine monophosphate-activated protein kinase induces cholesterol efflux from macrophage-derived foam cells and alleviates atherosclerosis in apolipoprotein E-deficient mice.Absence of Nceh1 augments 25-hydroxycholesterol-induced ER stress and apoptosis in macrophages Deficiency of glycine N-methyltransferase aggravates atherosclerosis in apolipoprotein E-null mice.Polymer particle shape independently influences binding and internalization by macrophages.Aiming drug discovery at lysophosphatidic acid targets.

P2860

Q24300059-D480DC80-E6F8-49F8-8755-0C73922CDF0F Q26738276-2FA3F40F-7065-4D63-8E28-290BB0A0C154 Q26780531-0FAF2A4D-D971-4387-A693-6FE354C2A300 Q26825052-65956745-2079-4235-B8AA-28955D16FBF9 Q26825935-8C466987-FE02-46C3-BAF1-69D2C73735A0 Q26828548-975A7B47-7E83-4E41-8D81-6408D8E2BC32 Q27311648-0758D6C6-5132-47E4-9AE2-4809283F30BF Q28071596-CEE9B78E-4372-4309-8D05-ADB8A3B57907 Q28083260-DF3091E1-BE85-4F3F-80A5-9D8C62DAEB85 Q28392848-3C048097-5EE8-434C-90E1-8C7F85FFC779 Q29620351-DADC05FC-F999-40FE-92C7-C85A94EF799D Q30426517-E4AB0C02-B2D3-4411-9794-5BA97A48FEAA Q30430126-58142513-670E-4273-A523-8CA083408057 Q30433527-12714E0F-0098-421B-A5F9-B96719A13C49 Q30450437-30B944F2-BD57-462E-99E0-621D54D592C4 Q30462417-7AD39985-7B74-442A-BF3F-EB7D5B4A8834 Q30469448-0B6A2009-498F-4C91-89E3-CB47EA3DC4A8 Q30484224-2B32F863-1E36-40FA-97E4-DB90B26FE807 Q30488574-9D6115A8-BDC7-45B0-9DA9-DA757C09965D Q31082775-00BCF8A2-6C42-44C5-83E0-E3E3A6B4BA46 Q33270217-A1880B57-819D-4B8B-99E4-1AF814FEC52E Q33294985-412C6CDF-2AF3-4AAA-A875-DD8E90BD293F Q33424019-013DDF71-E33C-4957-BF7D-5AC2033934C8 Q33547771-F83F35C0-44C1-4E13-BA53-C070342398C1 Q33817168-DEA7D60F-32E3-4072-BAA2-F18C3C362A2B Q33824589-C23D2DA9-4B3A-458A-92E8-22AA7D5B73EA Q33905863-073CEF1D-7D8E-4496-89B0-DF85306DBA15 Q33906710-1CE377AB-F2D7-4841-A261-E17F0042E2D6 Q33936780-8D83DF9C-AFB3-4B9E-8FDD-19FCB85AD809 Q33945439-C5A7C5F9-921C-4E28-ADF9-3D6FC0095495 Q34019117-2F8A7698-3EA6-4B03-BAEF-5AA6417A4491 Q34092833-EA0A9D80-265B-4516-82AE-970D233F7247 Q34115375-F1D54681-0CE4-40CA-A9DF-4D21E07C020D Q34123761-F1840BA7-63AB-435D-8399-8BA17AE8C0ED Q34149692-8B7CEE41-8A3E-41C0-AE2D-377159EEE50F Q34236808-278FB0F3-3690-4C09-9DDF-A872ACEDEE18 Q34238679-3C867821-540B-49C8-A84C-D1C8E6DC0EB0 Q34261102-B8A3D648-B242-4D03-9DDC-CF10276C46CF Q34288669-4B8B3878-AAC5-4912-952C-E1BBFB05C5FF Q34339759-5EA47742-03DA-4C43-81FA-E7D432377B52

P2860

The macrophage foam cell as a target for therapeutic intervention.

http://www.wikidata.org/entity/Q34986351

description

2002 nî lūn-bûn

@nan

2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

The macrophage foam cell as a target for therapeutic intervention.

@ast

The macrophage foam cell as a target for therapeutic intervention.

@en

The macrophage foam cell as a target for therapeutic intervention.

@nl

type

label

The macrophage foam cell as a target for therapeutic intervention.

@ast

The macrophage foam cell as a target for therapeutic intervention.

@en

The macrophage foam cell as a target for therapeutic intervention.

@nl

prefLabel

The macrophage foam cell as a target for therapeutic intervention.

@ast

The macrophage foam cell as a target for therapeutic intervention.

@en

The macrophage foam cell as a target for therapeutic intervention.

@nl

P1433

Q34986351-FD738F60-B870-40C7-A8D0-D20F01BCAB63

P1476

Q34986351-E21359A4-379B-4B34-946E-E0F33678C610

P2093

Q34986351-21215574-2D5D-433F-A54A-F53210FE6DB0

Q34986351-A7A83448-7AE8-42B1-8D42-9BCA918DED1B

P2860

Q34986351-02AC16A5-048D-46C4-AD20-1C19A0394DD9

Q34986351-08218BE7-3C55-4B54-A1CE-C87DB82BEF46

Q34986351-089A20A7-ACC0-4B8D-8E9A-7081E9D706EC

Q34986351-0D2957F7-3903-48A1-9E01-74B89EBBACD1

Q34986351-0FB874F8-07F0-40A4-A5C3-4AECBF0DBB5F

Q34986351-10B9DE9D-7254-4451-860D-2D7CBA63F186

Q34986351-13FABAED-8D89-4A82-8517-FF0CC72E9016

Q34986351-15417852-E32A-4597-AC0E-9625EDB307DD

Q34986351-187E8895-2BA7-4B6D-934E-E9325586BD2B

Q34986351-18A0AB77-2C5B-4E2D-8A2E-83B33FC6E20F

P2888

Q34986351-A4111238-8B06-49A1-901A-2C86BC23B304

P304

Q34986351-68D01BFF-6E76-40C6-91CA-15999A05270B

P31

Q34986351-A6F6B405-0119-4D89-9295-97B6F5E2B69A

P356

Q34986351-1D4B51C8-5DFF-4136-B12E-0CF5BB61C105

P407

Q34986351-7A24BAFC-204D-4EF3-910C-FC1B69FDDC9A

P433

Q34986351-CB401F7A-1AB9-4018-BD7B-B66B6F896731

P478

Q34986351-56502683-559A-4393-99F9-D5CCE6768947

P577

Q34986351-09C31A67-546B-4CBD-A2EF-5EBA390325C5

P5875

Q34986351-8F0DC947-C618-433A-89CD-D878F5508BAB

P698

Q34986351-4D336F01-4857-4D39-BD48-A4A48F659872

P921

Q34986351-E8679F90-10B0-4514-B5F5-B3D8CAE0CB56

P356

P1433

Nature Medicine

P1476

The macrophage foam cell as a target for therapeutic intervention.

@en

P2093

Andrew C Li

http://www.w3.org/2001/XMLSchema#string

Christopher K Glass

http://www.w3.org/2001/XMLSchema#string

P2860

Synthetic LXR ligand inhibits the development of atherosclerosis in mice

LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes

Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice

Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood

Atherosclerosis — An Inflammatory Disease

A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis

Identification of scavenger receptor SR-BI as a high density lipoprotein receptor

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

P2888

P304

1235-1242

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM1102-1235

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11053096

http://www.w3.org/2001/XMLSchema#string

P698

12411950

http://www.w3.org/2001/XMLSchema#string

P921